EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Differential DNA methylation and gene expression in stem cell-derived cardiomyocytes from patients with and without a history of clozapine-induced myocarditis

Diogo F Marques, Leticia M Spindola, Ankita Narang, Nazanin Vaziri, Anne-Kristin Stavrum, Mahesh Jayaram, Naveen Thomas, Christos Pantelis, Stephanie Le Hellard, Myriam Hemberger, Wendy Dean, Steven C Greenway und 1 weitere

Journal of Psychiatry and Neuroscience · 2025

DOI: 10.1139/jpn-25-0017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Psychiatry and Neuroscience, 2025. Verfasst von Diogo F Marques und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. Hauptthemen laut MEDLINE: Clozapine, DNA Methylation, Myocarditis, Antipsychotic Agents. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Mathison Centre for Mental Health Research and Education, Cumming School of Medicine, University of Calgary, Alberta Innovates.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clozapine is an effective antipsychotic medication for the management of treatment-resistant schizophrenia. However, the use of clozapine is limited due to severe and sometimes fatal adverse events, including cardiac inflammation (myocarditis). To date, studies of clozapine dosing and genetic studies have not identified robust risk markers. Our study aimed to identify potential epigenetic markers for clozapine-induced myocarditis using genome-wide profiling of DNA methylation and RNA sequencing in a novel in vitro model using patient-derived cells. Induced pluripotent stem cells (iPSCs) from treatment-resistant schizophrenia patients with (case) and without (control) a history of clozapine-induced myocarditis were differentiated into beating cardiomyocytes (iPSC-CMs). These cells were exposed to clozapine at a physiologically relevant concentration (2.8 µmol/L) for 24 h. Before and after clozapine treatment, RNA from the iPSC-CMs was sequenced (RNA-seq), and DNA was assessed for methylation using the EPIC array. Our analysis revealed that hypermethylation at the promoter regions of GSTM1 and ZNF559 is associated with reduced gene expression in cases relative to controls, regardless of clozapine exposure. Additionally, hypermethylation in the gene bodies of AKAP7 and HLA-DRB1 was associated with increased expression in cases relative to controls. Conversely, hypomethylation in the gene bodies of GAL3ST3 and PDPR correlated with lowered gene expression in cases relative to controls. These findings highlight a potential involvement of DNA methylation in gene expression regulation and its putative impact on clozapine-induced myocarditis. Additional studies are warranted to validate our findings and further elucidate a potential mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClozapineDNA MethylationMyocarditisAntipsychotic AgentsMyocytes, CardiacInduced Pluripotent Stem CellsSchizophrenia, Treatment-ResistantGene ExpressionHumansMaleAdultFemaleMiddle AgedEpigenesis, GeneticCell Differentiation

Stichwörter der Autor:innen

antipsychoticsepigeneticsschizophreniatranscriptomics

Substanzen

ClozapineAntipsychotic Agents

Autor:innen und Institutionen

  • Department of Medical Genetics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Dr. Einar Martens Research Group for Biological Psychiatry, Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
  • Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway.

Förderung

  • Mathison Centre for Mental Health Research and Education
  • Cumming School of Medicine, University of Calgary
  • Alberta Innovates

Zitieren

APA

Marques, D., Spindola, L., Narang, A., Vaziri, N., Stavrum, A., Jayaram, M., Thomas, N., Pantelis, C., Le Hellard, S., Hemberger, M., Dean, W., Greenway, S., & Bousman, C. (2025). Differential DNA methylation and gene expression in stem cell-derived cardiomyocytes from patients with and without a history of clozapine-induced myocarditis. Journal of Psychiatry and Neuroscience. https://doi.org/10.1139/jpn-25-0017

Vancouver

Marques D, Spindola L, Narang A, Vaziri N, Stavrum A, Jayaram M, et al. Differential DNA methylation and gene expression in stem cell-derived cardiomyocytes from patients with and without a history of clozapine-induced myocarditis. Journal of Psychiatry and Neuroscience. 2025. doi:10.1139/jpn-25-0017

BibTeX
@article{Marques2025,
  author = {Marques, Diogo F and Spindola, Leticia M and Narang, Ankita and Vaziri, Nazanin and Stavrum, Anne-Kristin and Jayaram, Mahesh and Thomas, Naveen and Pantelis, Christos and Le Hellard, Stephanie and Hemberger, Myriam and Dean, Wendy and Greenway, Steven C and Bousman, Chad},
  title = {Differential DNA methylation and gene expression in stem cell-derived cardiomyocytes from patients with and without a history of clozapine-induced myocarditis},
  journal = {Journal of Psychiatry and Neuroscience},
  year = {2025},
  doi = {10.1139/jpn-25-0017}
}
Kostenlos starten →